U.S. Electronic Equipment and Components Stock News

NasdaqGS:KDP
NasdaqGS:KDPBeverage

Keurig Dr Pepper (KDP) Former Executive Mauricio Leyva Takes Top Job At 7 Eleven

Mauricio Leyva, former Group President of Keurig Dr Pepper, has been appointed CEO of 7-Eleven, Inc. The leadership change places a recent senior Keurig Dr Pepper executive at the helm of one of its key retail partners. Keurig Dr Pepper, traded as NasdaqGS:KDP, enters this news cycle with its shares at $29.67 and a mixed recent track record. The stock is up 7.0% year to date, while returns over 1 year, 3 years, and 5 years show declines of 7.8%, 4.6%, and 3.9% respectively. In that context,...
NYSE:MUX
NYSE:MUXMetals and Mining

Can McEwen (MUX) Justify Its Valuation On New NI 43 101 Resource Reports?

McEwen (NYSE:MUX) is back in focus after filing NI 43-101 technical reports for its Grey Fox Project in Ontario and its Lookout Mountain and Windfall deposits in Nevada, updating investors on reserves and resources. See our latest analysis for McEwen. Against this backdrop of fresh technical data, McEwen’s share price has softened in the short term, with a 1 day share price return showing a 2.22% decline and a 90 day share price return down 27.46%. However, the 1 year total shareholder return...
NasdaqCM:LQDA
NasdaqCM:LQDAPharmaceuticals

Liquidia (LQDA) Could Be 23% Overvalued As Shares Push Above Analyst Fair Value

Liquidia (LQDA) drew fresh attention after the stock climbed 8.2% on Wednesday to close at $87.50, extending a rally that persisted despite skeptical commentary about the strength of the bullish case. See our latest analysis for Liquidia. The latest move takes Liquidia’s share price to $89.03, extending a strong run that includes a 20.25% 1 month share price return and 138.62% 3 month share price return, alongside a very large 5 year total shareholder return. If you are looking beyond...
NasdaqGS:CLBT
NasdaqGS:CLBTSoftware

Cellebrite Stock Leads 3 Rate Sensitive Growth Names Facing The Fed Debate

With the Federal Reserve’s next move unclear and Chair Kevin Warsh reaffirming a 2% inflation goal, rate sensitive growth stocks are back in the spotlight. When borrowing costs and policy timelines are uncertain, some companies can see their growth stories questioned while others may look better positioned to handle higher funding costs or sharper swings in sentiment. This article looks at three stocks from the Rate Sensitive Growth Stocks screener that appear more exposed to the current Fed...
NasdaqGS:HBNC
NasdaqGS:HBNCBanks

Does Rising Net Interest Income Outweigh Higher Credit Costs For Horizon Bancorp’s Core Earnings Story (HBNC)?

Horizon Bancorp, Inc. recently reported its second-quarter 2026 results, with net interest income rising to US$63.49 million and net income to US$24.91 million, while net charge-offs increased to US$605,000 from US$254,000 a year earlier. Despite higher credit costs, the company delivered higher earnings per share from continuing operations, suggesting that core banking performance more than offset the increased charge-offs. Next, we will explore how Horizon Bancorp’s stronger net interest...
NYSE:ONON
NYSE:ONONLuxury

Bloom Energy Stock And 2 AI Infrastructure Picks Trading On Strong Cash Flow

Global growth indicators are finally showing some life again, with services and manufacturing activity stabilizing across major regions while inflation pressures look less one sided. In this kind of mixed but improving backdrop, investors often look for solid companies that already generate cash, carry sensible levels of debt, and still trade on undemanding valuations. That is exactly what the High Quality Undervalued Stocks screener aims to filter for by highlighting businesses with balance...
NYSE:MRK
NYSE:MRKPharmaceuticals

Is Merck (MRK) A Bargain After FDA Approval For LIPFENDRA And HIV PrEP Expansion?

Merck (MRK) is back in the spotlight after securing FDA approval for LIPFENDRA, the first oral PCSK9 inhibitor for lowering LDL cholesterol, alongside fresh plans to widen access to its investigational HIV PrEP pill, alimatravir. See our latest analysis for Merck. Merck’s recent updates around LIPFENDRA and alimatravir come as the stock trades at US$130.48, with a 30-day share price return of 9.1% and year-to-date share price return of 22.6%, while the 1-year total shareholder return of 60.3%...
NasdaqGS:BWIN
NasdaqGS:BWINInsurance

Baldwin Insurance Group (BWIN) Could Be 12% Undervalued After Rising Earnings Optimism

Recent analyst optimism around Baldwin Insurance Group (BWIN) ahead of its upcoming June quarter earnings report has put a spotlight on expectations for higher earnings and revenues, drawing fresh attention to the stock. See our latest analysis for Baldwin Insurance Group. At a share price of $25.89, Baldwin Insurance Group has seen a 1 month share price return of 6.15% and an 8.87% share price return year to date, while the 1 year total shareholder return is down 35.71%. This suggests recent...
NYSE:L
NYSE:LInsurance

Loews (L) Stock Could Be 4% Overvalued As Earnings Look Pricey

Loews stock has delivered a strong 118.5% return over the past 5 years, and at a recent price of US$115.63, the valuation picture now looks tighter, with the intrinsic value estimate from the Excess Returns model sitting close to the market level while earnings based multiples lean on the expensive side. Loews' 118.5% 5 year return suggests long term shareholders have already captured considerable value, which can limit how much is left if expectations are already reflected in the price. For...
NasdaqGS:VC
NasdaqGS:VCAuto Components

Visteon (VC) Stock May Be 45% Undervalued On Cash Flow Potential

Visteon stock has declined about 33.3% over the past three years, yet the current valuation checks present a mixed picture, with the Discounted Cash Flow (DCF) intrinsic value estimate pointing to a sizeable gap between price and estimated worth while market based multiples look closer to fair. The roughly 33.3% share price decline over three years suggests sentiment around Visteon has weakened even as its current valuation signals are not uniformly negative. Expectations for the company’s...
NasdaqGS:AAPL
NasdaqGS:AAPLTech

Apple Stock And 2 U.S. Tech Giants Facing EU Tariff Pressure

Rising talk of new U.S. tariffs on European Union goods has put fresh attention on how exposed big American technology companies are to Brussels regulators and cross border trade tensions. While headlines focus on politics, the real question for you is which U.S. technology mega caps could benefit if pressure on the EU leads to regulatory relief expectations at home, and which might feel the strain from uncertainty around European revenue. This article looks at three positively exposed U.S...
NYSE:DAL
NYSE:DALAirlines

Delta Air Lines (DAL) Stock Still Looks Like A Bargain As It Doubled In 5 Years

Delta Air Lines stock has more than doubled over the past five years, and after that strong run, investors are weighing whether the current price still lines up with what the broader valuation checks suggest about its appeal. Over 5 years, Delta Air Lines has returned 106.0%, which puts current holders in a strong position and raises the bar for fresh buyers looking for further upside from here. Solid demand and higher fares can support earnings, while sensitivity to fuel and labor costs may...
NYSE:ACI
NYSE:ACIConsumer Retailing

Albertsons (ACI) Cuts 2026 Outlook As Restructure And CFO Exit Add Pressure

Albertsons Companies (NYSE:ACI) cut its fiscal 2026 sales and profit outlook, citing softer demand and higher reinvestment needs. The company plans a broad operational restructuring, including consolidating divisions to streamline its grocery operations. Albertsons also announced that its Chief Financial Officer intends to retire, adding leadership changes to an already active period of transition. For investors watching Albertsons Companies, these updates arrive after a tough period for...
NYSE:VPG
NYSE:VPGElectronic

Vishay Precision Group (VPG) After The Robotics And Automation Narrative Meets Fair Value

Vishay Precision Group (VPG) has drawn investor attention after recent share price swings, with the stock moving sharply in the past 3 months and over the past year. These shifts invite a closer look at fundamentals. See our latest analysis for Vishay Precision Group. At a share price of $110.54, Vishay Precision Group has seen short term momentum cool, with a 1 month share price return down 17.61%. However, a 90 day share price return of 82.35% and a 1 year total shareholder return of...
NYSE:KEX
NYSE:KEXShipping

How Investors May Respond To Kirby (KEX) Analysts’ Brighter View Of June-Quarter Earnings Potential

In recent days, analysts have become more optimistic about Kirby Corporation’s June 2026 quarter, expecting year-over-year earnings growth on higher revenue, with the earnings report released on July 29 now in the past. This shift in sentiment, reflected in a positive Earnings ESP and favorable Zacks Rank, pointed to a potential earnings beat that drew increased investor attention. With analysts having turned more optimistic ahead of the June-quarter results, we’ll examine how this improved...
NYSE:COF
NYSE:COFConsumer Finance

Capital One (COF) Faces Zelle Lawsuit As Canada Data Breach Settlement Progresses

New York Attorney General files a lawsuit alleging widespread consumer fraud on the Zelle payments network, naming Capital One Financial (NYSE:COF) as a co-owner and key shareholder. The case centers on claims that Zelle prioritized growth over security, leading to systemic losses for customers using participating banks. Separately, Capital One reaches a C$35 million settlement in Canada tied to a previous data breach, addressing part of its outstanding legal exposure. Capital One...
NasdaqGS:FFBC
NasdaqGS:FFBCBanks

Does First Financial Bancorp’s (FFBC) Finward Deal Mark a Strategic Shift in Growth Priorities?

First Financial Bancorp. recently reported second-quarter 2026 results showing higher net interest income of US$190.38 million and net income of US$76.46 million compared with a year earlier, while also declaring a quarterly dividend of US$0.26 per share payable on September 15, 2026. The bank is pairing this earnings momentum with expansion, announcing an acquisition of Finward Bancorp that is expected to increase earnings per share and deepen its presence in Northwest Indiana and the...
NYSE:IEX
NYSE:IEXMachinery

IDEX (IEX) Could Be 7% Below Fair Value As Earnings Near

IDEX (IEX) is back in focus as investors look ahead to its June 2026 earnings report, with expectations for higher earnings and revenue, although recently reduced profit forecasts are tempering confidence. See our latest analysis for IDEX. The IDEX share price has eased in the very short term, with a 1-day share price return that declined 0.42% and a 7-day share price return down 2.94%, but the picture is more constructive over longer periods, including a 90-day share price return of 8.54%, a...
NYSE:AIT
NYSE:AITTrade Distributors

Applied Industrial Technologies (AIT) Stock Looks Fully Priced On Cash Flow And Earnings

Applied Industrial Technologies has delivered a very large 304.9% total return over the past five years, yet current checks suggest the stock may now be trading at a premium, with both its Discounted Cash Flow (DCF) intrinsic value estimate and market multiples pointing to overvaluation. Over the last five years, a 304.9% return puts Applied Industrial Technologies among the stronger long term performers, which naturally raises the question of how much of that success is already embedded in...
NasdaqGM:PTGX
NasdaqGM:PTGXBiotechs

Protagonist Therapeutics (PTGX) Stock Looks Stretched As A Price Target Boost Lands

Protagonist Therapeutics has delivered a very large 3 year return, yet its current valuation screens as expensive on market multiples and only mixed on broader checks, which raises questions about how much optimism is already in the share price. Over the past 3 years, Protagonist Therapeutics has returned roughly 7x, which puts extra focus on whether recent gains can be supported by fundamentals over time. Recent enthusiasm around the company, including a higher price target from Barclays,...
NYSE:ETR
NYSE:ETRElectric Utilities

Why Retail Investors Are Looking At Entergy Stock And Other US Utility Safe Havens

With oil prices above US$100 per barrel, rising geopolitical risks in the Middle East and renewed pressure on growth sectors after higher AI spending plans, many investors are taking a closer look at larger U.S. utilities stocks for potential ballast in a more volatile market. This article walks through how those macro shocks connect to the Utilities Stocks screener and what that might mean for risk, income and capital allocation. It will also reveal 3 stocks from the screener that appear...
NYSE:HIG
NYSE:HIGInsurance

The Bull Case For Hartford (HIG) Could Change Following Strong Q2 Results And $4.2B Buyback Expansion

The Hartford Insurance Group reported past second-quarter 2026 results with revenue of US$7.26 billion and net income of US$1.30 billion, while authorizing a new share repurchase program of up to US$4.20 billion through 2028 and affirming both common and preferred dividends. Alongside these earnings and capital return moves, The Hartford strengthened its governance and risk oversight by adding former AssuredPartners CEO Randy Larsen to its board and receiving an AM Best affirmation of its A+...
NYSE:TROX
NYSE:TROXChemicals

Is Tronox Holdings (TROX) Cheap After Its Pullback And A $7.03 Fair Value?

Tronox Holdings (TROX) has drawn fresh attention after its recent share move, with the stock closing at $6.38. Investors are weighing this price against the company’s fundamentals and recent return profile. See our latest analysis for Tronox Holdings. Tronox Holdings’ recent pullback to a 1 day share price return of down 3.63% comes after a strong year to date share price return of 49.41%. The 1 year total shareholder return of 18.60% contrasts with a weaker 3 and 5 year total shareholder...